#CollPlant

Thiard News@F4F

@newsen.bsky.social

4 days ago

CollPlant Biotechnologies Set to Reveal 2025 Financial Results on March 26, 2026 CollPlant Biotechnologies, recognized for its innovative biotechnological solutions in medical aesthetics, will announce its financial results for 2025 on March 26, 2026, prior to U.S. market opening.

CollPlant Biotechnologies Set to Reveal 2025 Financial Results on March 26, 2026 #Israel #biotechnology #CollPlant #rhCollagen #Rehovot

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

CollPlant Biotechnologies Achieves Key Patent Milestone in South Korea for Innovative Dermal Filler Technology CollPlant Biotechnologies announces the successful patent allowance for their photocurable dermal filler technology in South Korea, marking a significant milestone.

CollPlant Biotechnologies Achieves Key Patent Milestone in South Korea for Innovative Dermal Filler Technology #Israel #CollPlant #rhCollagen #Rehovot #dermal_filler

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

CollPlant Unveils BioFlex: A Next-Generation Solution for Advanced 3D Bioprinting of Tissues CollPlant announces the launch of BioFlex, a ready-to-print bioprinting kit that enhances the creation of complex tissue models, crucial for regenerative medicine.

CollPlant Unveils BioFlex: A Next-Generation Solution for Advanced 3D Bioprinting of Tissues #Israel #CollPlant #rhCollagen #Rehovot #BioFlex

Thiard News@F4F

@newsen.bsky.social

1 month ago

CollPlant Biotechnologies Initiates $2 Million Direct Offering for Growth and Innovation CollPlant Biotechnologies unveils a $2 million direct offering to boost growth in regenerative medicine, focusing on innovative rhCollagen products.

CollPlant Biotechnologies Initiates $2 Million Direct Offering for Growth and Innovation #Israel #CollPlant #rhCollagen #Rehovot #regenerative_medicine

Thiard News@F4F

@newsen.bsky.social

3 months ago

CollPlant Biotechnologies Reports Third Quarter 2025 Financial Results and Major Corporate Developments CollPlant Biotechnologies has released its financial results for the third quarter of 2025, highlighting growth in rhCollagen sales and a new logistics partnership in North America.

CollPlant Biotechnologies Reports Third Quarter 2025 Financial Results and Major Corporate Developments #Israel #CollPlant #rhCollagen #Rehovot #Bioink

Thiard News@F4F

@newsen.bsky.social

4 months ago

CollPlant Boosts North American Presence with New Logistics Center for rhCollagen and BioInk CollPlant Biotechnologies has announced the opening of a new logistics center in the U.S., enhancing their distribution of rhCollagen and BioInk products for markets in the U.S. and Canada.

CollPlant Boosts North American Presence with New Logistics Center for rhCollagen and BioInk #United_States #CollPlant #rhCollagen #Rehovot #Bioink

Thiard News@F4F

@newsen.bsky.social

4 months ago

CollPlant's Innovative BioInk Shows Superior Performance Over Matrigel® in Advanced Tissue Engineering A recent study by Technion reveals CollPlant's rhCollagen-based bioink, Collink.3D™, outmatching Matrigel® in tissue formation. Promoting eco-friendly practices in engineering.

CollPlant's Innovative BioInk Shows Superior Performance Over Matrigel® in Advanced Tissue Engineering #Israel #CollPlant #Rehovot #Collink.3D #Technion

Thiard News@F4F

@newsen.bsky.social

4 months ago

Mayo Clinic Innovates with Humanized 3D Bioprinted Skin Model Using Plant-Based BioInk Mayo Clinic researchers have developed a groundbreaking 3D bioprinted human skin model using innovative plant-derived bioink. This advancement offers an ethical alternative to animal testing for medical research.

Mayo Clinic Innovates with Humanized 3D Bioprinted Skin Model Using Plant-Based BioInk #United_States #Rochester #CollPlant #rhCollagen #Mayo_Clinic

Thiard News@F4F

@newsen.bsky.social

5 months ago

CollPlant Biotechnologies Reveals Promising Non-Clinical Results for Innovative Photocurable Dermal Filler CollPlant Biotechnologies announces encouraging outcomes from its non-clinical studies on a groundbreaking photocurable dermal filler, paving the way for clinical trials.

CollPlant Biotechnologies Reveals Promising Non-Clinical Results for Innovative Photocurable Dermal Filler #Israel #CollPlant #rhCollagen #Rehovot #dermal_filler

Thiard News@F4F

@newsen.bsky.social

6 months ago

CollPlant Boosts Distribution of Vergenix STR Across Europe with New Agreement CollPlant Biotechnologies announces expanded European distribution for its Vergenix STR product, aimed at enhancing tendon healing across multiple indications.

CollPlant Boosts Distribution of Vergenix STR Across Europe with New Agreement #Israel #CollPlant #rhCollagen #Rehovot #Vergenix_STR

Thiard News@F4F

@newsen.bsky.social

6 months ago

CollPlant Set to Showcase Innovations at the 2025 Global Biofabrication Conference CollPlant Biotechnologies will present groundbreaking advancements in biofabrication at the upcoming international conference in Warsaw, Poland.

CollPlant Set to Showcase Innovations at the 2025 Global Biofabrication Conference #Warsaw #Poland #CollPlant #rhCollagen #Biofabrication

Thiard News@F4F

@newsen.bsky.social

6 months ago

CollPlant to Showcase Innovative Biotechnologies at H.C. Wainwright Conference Join CollPlant Biotechnologies as they present groundbreaking advancements in regenerative medicine at the 27th Global Investment Conference in New York.

CollPlant to Showcase Innovative Biotechnologies at H.C. Wainwright Conference #United_States #New_York #CollPlant #rhCollagen #Allergan

Thiard News@F4F

@newsen.bsky.social

6 months ago

CollPlant Biotechnologies Reports 2025 Second Quarter Financial Results and Corporate Developments CollPlant Biotechnologies reveals its financial results for Q2 2025 and announces significant advancements in its regenerative medicine products and corporate strategy.

CollPlant Biotechnologies Reports 2025 Second Quarter Financial Results and Corporate Developments #Israel #CollPlant #rhCollagen #Rehovot #Aesthetic_Medicine

Thiard News@F4F

@newsen.bsky.social

7 months ago

CollPlant Biotechnologies to Report Second Quarter Financial Results Soon CollPlant Biotechnologies has announced that it will disclose its financial results for the second quarter on August 20, 2025, before market opening.

CollPlant Biotechnologies to Report Second Quarter Financial Results Soon #Israel #CollPlant #rhCollagen #Rehovot #Allergan

Thiard News@F4F

@newsen.bsky.social

8 months ago

CollPlant's New VP to Spearhead North American Commercial Growth Strategy CollPlant Biotechnologies has appointed Bowman Bagley as VP of North America Commercial Operations to drive growth and expand market presence.

CollPlant's New VP to Spearhead North American Commercial Growth Strategy #Israel #CollPlant #rhCollagen #Rehovot #Bowman_Bagley

Thiard News@F4F

@newsen.bsky.social

9 months ago

CollPlant and STEMCELL Technologies Expand Partnership for Regenerative Medicine Applications CollPlant Biotechnologies enhances collaboration with STEMCELL Technologies to broaden applications for its rhCollagen in regenerative medicine and aesthetics.

CollPlant and STEMCELL Technologies Expand Partnership for Regenerative Medicine Applications #Israel #CollPlant #rhCollagen #Rehovot #STEMCELL

Thiard News@F4F

@newsen.bsky.social

9 months ago

CollPlant Secures European Patent for Innovative Collagen-Based Fillers and Implants CollPlant Biotechnologies has received a European patent for its groundbreaking collagen-based formulations used in soft tissue fillers and implants, enhancing its market strategy significantly.

CollPlant Secures European Patent for Innovative Collagen-Based Fillers and Implants #Israel #CollPlant #rhCollagen #breast_implants #Rehovot

Thiard News@F4F

@newsen.bsky.social

9 months ago

CollPlant Biotechnologies Announces $3.6 Million Direct Offering Amidst Growth in Regenerative Medicine CollPlant Biotechnologies has initiated a $3.6 million registered direct offering to bolster its regenerative medicine initiatives. This strategic decision is aimed at enhancing their market presence and executing long-term growth.

CollPlant Biotechnologies Announces $3.6 Million Direct Offering Amidst Growth in Regenerative Medicine #Israel #CollPlant #rhCollagen #Rehovot #regenerative_medicine

Thiard News@F4F

@newsen.bsky.social

9 months ago

CollPlant Biotechnologies Reports Promising Progress in Regenerative Medicine for 2025 Q1 CollPlant Biotechnologies announces positive financial results and strategic advancements in its regenerative medicine programs for Q1 2025, including innovative collaborations.

CollPlant Biotechnologies Reports Promising Progress in Regenerative Medicine for 2025 Q1 #Israel #CollPlant #rhCollagen #Rehovot #AbbVie

Thiard News@F4F

@newsen.bsky.social

10 months ago

CollPlant Biotechnologies to Announce Q1 Financial Results on May 28, 2025 CollPlant Biotechnologies reveals the date for their first quarter financial results, emphasizing its innovations in regenerative medicine.

CollPlant Biotechnologies to Announce Q1 Financial Results on May 28, 2025 #Israel #CollPlant #rhCollagen #Rehovot #Allergan

Thiard News@F4F

@newsen.bsky.social

11 months ago

CollPlant's Innovative BioInks Support FDA's Plan to Reduce Animal Testing in Drug Development CollPlant's rhCollagen BioInks align with the FDA's initiative to replace animal testing, providing economical solutions for drug development.

CollPlant's Innovative BioInks Support FDA's Plan to Reduce Animal Testing in Drug Development #Israel #CollPlant #Rehovot #Bioink #FDA_Initiative

Thiard News@F4F

@newsen.bsky.social

11 months ago

CollPlant Biotechnologies Unveils 2024 Financial Update and Future Directions CollPlant Biotechnologies announces its 2024 financial results, highlighting innovations in regenerative medicine and strategic collaborations, particularly with AbbVie.

CollPlant Biotechnologies Unveils 2024 Financial Update and Future Directions #Israel #CollPlant #rhCollagen #Rehovot #AbbVie

Thiard News@F4F

@newsen.bsky.social

1 year ago

CollPlant Accelerates Global Reach with VergenixSTR Product Expansion in Europe and Asia CollPlant Biotechnologies announces significant distribution agreements for its VergenixSTR product in Europe and Asia, targeting tendon injuries.

CollPlant Accelerates Global Reach with VergenixSTR Product Expansion in Europe and Asia #Israel #CollPlant #rhCollagen #Rehovot #VergenixSTR

Thiard News@F4F

@newsen.bsky.social

1 year ago

CollPlant Biotechnologies Unveils Corporate Updates and Innovations CollPlant Biotechnologies shares significant developments, including new patents and cost reduction plans, aiming for growth in regenerative medicine.

CollPlant Biotechnologies Unveils Corporate Updates and Innovations #Israel #CollPlant #rhCollagen #Rehovot #dermal_filler

Thiard News@F4F

@newsen.bsky.social

1 year ago

CollPlant Biotechnologies Unveils Promising Breast Implant Developments with Third Quarter Financial Update CollPlant Biotechnologies shares encouraging news from its third quarter report, showcasing advancements in its breast implant technology and financial updates.

CollPlant Biotechnologies Unveils Promising Breast Implant Developments with Third Quarter Financial Update #None #CollPlant #rhCollagen #breast_implants #Rehovot